Qtox 100U 5 vials

Qtox 100U is a KFDA-approved botulinum toxin type A manufactured in South Korea for the export market. It is positioned as an alternative to Nabota and is produced using a highly purified manufacturing process.

Some patients may experience a reduced response to botulinum toxin treatments over time. This may be associated with the development of neutralizing antibodies or individual variations in how the body responds to or metabolizes the toxin.

Qtox is formulated with a highly purified neurotoxin to help minimize unnecessary complexing proteins, making it a suitable option for practitioners seeking an alternative product for patients who have experienced a diminished response to other botulinum toxin brands.

According to the manufacturer, Qtox is produced using an advanced purification process designed to reduce immunogenicity. Any claims regarding antibody formation or resistance rates should be interpreted in accordance with the manufacturer’s published clinical data and regulatory documentation.